A recent article published earlier this month in Frontier in Cellular and Infection Microbiology, recognized R. Jude Samulski, Ph.D., as the most cited and co-cited expert for AAV gene therapy advancements. Here are the details.
Read More
Sheila Mikhail, a pioneer and thought leader in genetics, is stepping down as CEO of AskBio, a company she co-founded and later sold to global giant Bayer AG.
Read More
Gene therapy company AskBio of Research Triangle Park has signed a multi-year research collaboration and option agreement with ReCode Therapeutics to develop gene-editing technology for driving new precision therapies.
Read More
The European Society of Gene and Cell Therapy (ESGCT), a nonprofit organization supporting scientists and clinicians, recognized gene therapy pioneer and entrepreneur Jude Samulski, Ph.D., with its inaugural Founders Award.
Read More
Seventeen months after negotiating a whopping $4 billion buyout deal with German pharma giant Bayer, Asklepios BioPharmaceutical (AskBio) CEO and co-founder Sheila Mikhail says the pioneering gene therapy company is hitting all its targets. And she continues to wage her own battle with lupus.
Read More
AskBio, Passport, BioSkryb, Catalyst Clinical, ABBY and ThermoFisher are making news. Here are the headlines.
Read More
Sheila Mikhail, co-founder and chief executive officer of Asklepios BioPharmaceutical (AskBio), a gene therapy pioneer that was acquired by Bayer AG last year for $4 billion, has been named national Entrepreneur of the Year by Ernst & Young, the accounting and business services firm.
Read More
Durham medical device company EmitBio Inc. thinks it has seen the light when it comes to treating COVID-19. Here are the details.
Read More
Our Tech Today wrapup includes headline-making news from the V Foundation, Honeywell, AskBio, CommScope, Worldwide Clinical Trials and AeroMed.
Read More
